Skip to content

Neurogene Inc.: 10-K filed 2015-03-16

What Neurogene Inc. reported in its annual report filed 2015-03-16 (fiscal FY 2014): 30 published measures, 77 facts as tagged in accession 0001193125-15-093873.

This filing

Form
10-K (annual report)
Filed
2015-03-16
Fiscal period
fiscal FY 2014
Accession
0001193125-15-093873 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Neurogene Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-12-3141,422,947USD
At 2013-12-3115,649,106USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-12-315,275,649USD
At 2013-12-317,484,092USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-12-3136,147,298USD
At 2014-03-12-65,388,547USD
At 2013-12-31-65,693,708USD
At 2012-12-31-51,101,207USD
At 2011-12-31-39,314,581USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2014-12-3114,906,087USD
At 2013-12-3111,006,392USD
At 2012-12-312,000,539USD
At 2011-12-319,239,188USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-03-13 to 2014-12-31-24,027,016USD294
2014-01-01 to 2014-12-31-24,027,016USD365
2013-01-01 to 2013-12-31-8,729,371USD365
2012-01-01 to 2012-12-31-7,714,198USD366

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-12-31113,890USD365
2013-01-01 to 2013-12-3111,741USD365
2012-01-01 to 2012-12-316,447USD366

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-12-31-89,415,563USD
At 2013-12-31-65,693,708USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-222USD365
2013-01-01 to 2013-12-31-5,044USD365
2012-01-01 to 2012-12-3142,294USD366

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-12-31104,694USD
At 2013-12-3175,465USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-12-31854,188USD365
2013-01-01 to 2013-12-31349,321USD365
2012-01-01 to 2012-12-31351,322USD366

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-12-3139,301,759USD
At 2013-12-3115,296,351USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2014-01-01 to 2014-12-31461,587USD365
2013-01-01 to 2013-12-3142,923USD365
2012-01-01 to 2012-12-319,470USD366

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-12-315,203,308USD
At 2013-12-312,620,105USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-01-01 to 2014-12-3122,375,709USD365
2013-01-01 to 2013-12-319,375,655USD365
2012-01-01 to 2012-12-317,681,018USD366

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-01-01 to 2014-12-3118,079,262USD365
2013-01-01 to 2013-12-317,598,750USD365
2012-01-01 to 2012-12-316,045,395USD366

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-12-3110,695,108shares
At 2013-12-31301,745shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-12-31125,566,705USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-12-31-3,855USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-12-31382,561USD
At 2013-12-31328,194USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-12-31277,867USD
At 2013-12-31252,729USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-12-3113,395USD
At 2013-12-31277,290USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2013-12-318,560USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2014-12-310USD
At 2013-12-310USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-24,027,238USD365
2013-01-01 to 2013-12-31-8,734,415USD365
2012-01-01 to 2012-12-31-7,671,904USD366

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-24,030,871USD365
2013-01-01 to 2013-12-31-8,729,371USD365
2012-01-01 to 2012-12-31-7,714,198USD366

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-23,821,276USD365
2013-01-01 to 2013-12-31-14,941,829USD365
2012-01-01 to 2012-12-31-12,137,948USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-01-01 to 2014-12-314,296,447USD365
2013-01-01 to 2013-12-311,776,905USD365
2012-01-01 to 2012-12-311,635,623USD366

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2014-01-01 to 2014-12-31135,946USD365
2013-01-01 to 2013-12-3159,571USD365
2012-01-01 to 2012-12-31130,784USD366

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-254,890USD365
2013-01-01 to 2013-12-31108,942USD365
2012-01-01 to 2012-12-3164,032USD366

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-01-01 to 2014-12-31-1,651,529USD365
2013-01-01 to 2013-12-31641,240USD365
2012-01-01 to 2012-12-319,114USD366

Inspect the source

Entity
Neurogene Inc. / CIK 0001404644
Captured
SEC response SHA-256
87b159cd5ceebdf479b494be364ba33f1e8263d79fdedbf945f7fab03349e1a8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001404644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))